Metformin (Uzbek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Metformin" in Uzbek language version.

refsWebsite

Global rank Uzbek rank

2^nd place

3^rd place

4^th place

7^th place

11^th place

82^nd place

low place

2,158^th place

apteka.uz

Dunn CJ, Peters DH (May 1995). „Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus“. Drugs. 49-jild, № 5. 721–49-bet. doi:10.2165/00003495-199549050-00007. PMID 7601013.
Hundal RS, Inzucchi SE (2003). „Metformin: new understandings, new uses“. Drugs. 63-jild, № 18. 1879–94-bet. doi:10.2165/00003495-200363180-00001. PMID 12930161.
American Diabetes Association (2022). „Introduction: Standards of Medical Care in Diabetes—2022“. Diabetes Care. 45-jild, № Suppl 1. S1–S2-bet. doi:10.2337/dc22-Sint. PMID 34964812. S2CID 245454068.
Wheeler, David C.; et al. (2020). „2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD“. European Heart Journal. 41-jild, № 2. 255–323-bet. doi:10.1093/eurheartj/ehz486. PMID 31497854.
Wheeler, David C.; et al. (2020). „2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD“. European Heart Journal. 41-jild, № 2. 255–323-bet. doi:10.1093/eurheartj/ehz486. PMID 31497854.
Maruthur NM, Tseng E, Hutfless S, Wilson LM, Suarez-Cuervo C, Berger Z, et al. (June 2016). „Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis“. Annals of Internal Medicine. 164-jild, № 11. 740–51-bet. doi:10.7326/M15-2650. PMID 27088241. S2CID 32016657.

Dunn CJ, Peters DH (May 1995). „Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus“. Drugs. 49-jild, № 5. 721–49-bet. doi:10.2165/00003495-199549050-00007. PMID 7601013.
Hundal RS, Inzucchi SE (2003). „Metformin: new understandings, new uses“. Drugs. 63-jild, № 18. 1879–94-bet. doi:10.2165/00003495-200363180-00001. PMID 12930161.
American Diabetes Association (2022). „Introduction: Standards of Medical Care in Diabetes—2022“. Diabetes Care. 45-jild, № Suppl 1. S1–S2-bet. doi:10.2337/dc22-Sint. PMID 34964812. S2CID 245454068.
Wheeler, David C.; et al. (2020). „2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD“. European Heart Journal. 41-jild, № 2. 255–323-bet. doi:10.1093/eurheartj/ehz486. PMID 31497854.
Wheeler, David C.; et al. (2020). „2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD“. European Heart Journal. 41-jild, № 2. 255–323-bet. doi:10.1093/eurheartj/ehz486. PMID 31497854.
Maruthur NM, Tseng E, Hutfless S, Wilson LM, Suarez-Cuervo C, Berger Z, et al. (June 2016). „Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis“. Annals of Internal Medicine. 164-jild, № 11. 740–51-bet. doi:10.7326/M15-2650. PMID 27088241. S2CID 32016657.

American Diabetes Association (2022). „Introduction: Standards of Medical Care in Diabetes—2022“. Diabetes Care. 45-jild, № Suppl 1. S1–S2-bet. doi:10.2337/dc22-Sint. PMID 34964812. S2CID 245454068.
Maruthur NM, Tseng E, Hutfless S, Wilson LM, Suarez-Cuervo C, Berger Z, et al. (June 2016). „Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis“. Annals of Internal Medicine. 164-jild, № 11. 740–51-bet. doi:10.7326/M15-2650. PMID 27088241. S2CID 32016657.